Literature DB >> 18608097

Implications of blood-brain barrier disruption in ALS.

Svitlana Garbuzova-Davis, Samuel Saporta, Paul R Sanberg.   

Abstract

Our letter to the editor addresses important questions regarding the role of the blood-spinal cord barrier in amyotrophic lateral sclerosis. The novel finding of barrier dysfunction in ALS has implications for disease pathogenesis. This discussion should prove of widespread interest to researchers and may help in formulating various new therapeutic strategies to protect barrier function and thus extend functionality and lifespan in ALS patients.

Entities:  

Mesh：

Year:  2008        PMID： 18608097     DOI： 10.1080/17482960802160990

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler        ISSN： 1471-180X


  21 in total

1.  Defective neuromuscular transmission in the SOD1 G93A transgenic mouse improves after administration of human umbilical cord blood cells.

Authors:  Nizar Souayah; K M Coakley; R Chen; Norman Ende; Joseph J McArdle
Journal:  Stem Cell Rev Rep       Date:  2012-03       Impact factor: 5.739

Review 2.  CSF markers in amyotrophic lateral sclerosis.

Authors:  Joanna Tarasiuk; Alina Kułakowska; Wiesław Drozdowski; Johannes Kornhuber; Piotr Lewczuk
Journal:  J Neural Transm (Vienna)       Date:  2012-05-04       Impact factor: 3.575

3.  Transplantation of human bone marrow stem cells into symptomatic ALS mice enhances structural and functional blood-spinal cord barrier repair.

Authors:  Svitlana Garbuzova-Davis; Edward Haller; Stephanie Navarro; Tony E Besong; Kayla J Boccio; Surafuale Hailu; Mohammed Khatib; Paul R Sanberg; Stanley H Appel; Cesario V Borlongan
Journal:  Exp Neurol       Date:  2018-08-30       Impact factor: 5.330

Review 4.  Motor neuron-immune interactions: the vicious circle of ALS.

Authors:  Ana G Barbeito; Pinar Mesci; Séverine Boillée
Journal:  J Neural Transm (Vienna)       Date:  2010-06-15       Impact factor: 3.575

5.  Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models.

Authors:  Sarah Logan; Thiago Arzua; Scott G Canfield; Emily R Seminary; Samantha L Sison; Allison D Ebert; Xiaowen Bai
Journal:  Compr Physiol       Date:  2019-03-14       Impact factor: 9.090

Review 6.  Propitious Therapeutic Modulators to Prevent Blood-Spinal Cord Barrier Disruption in Spinal Cord Injury.

Authors:  Hemant Kumar; Alexander E Ropper; Soo-Hong Lee; Inbo Han
Journal:  Mol Neurobiol       Date:  2016-05-18       Impact factor: 5.590

7.  Reduction of circulating endothelial cells in peripheral blood of ALS patients.

Authors:  Svitlana Garbuzova-Davis; Robert L Woods; Michael K Louis; Theresa A Zesiewicz; Nicole Kuzmin-Nichols; Kelly L Sullivan; Amber M Miller; Diana G Hernandez-Ontiveros; Paul R Sanberg
Journal:  PLoS One       Date:  2010-05-12       Impact factor: 3.240

Review 8.  Potential new complication in drug therapy development for amyotrophic lateral sclerosis.

Authors:  Svitlana Garbuzova-Davis; Avery Thomson; Crupa Kurien; R Douglas Shytle; Paul R Sanberg
Journal:  Expert Rev Neurother       Date:  2016-07-15       Impact factor: 4.618

9.  Phenotypic characteristics of human bone marrow-derived endothelial progenitor cells in vitro support cell effectiveness for repair of the blood-spinal cord barrier in ALS.

Authors:  Svitlana Garbuzova-Davis; Jared Ehrhart; Hilmi Mustafa; Alexander Llauget; Kayla J Boccio; Paul R Sanberg; Stanley H Appel; Cesario V Borlongan
Journal:  Brain Res       Date:  2019-09-04       Impact factor: 3.252

10.  Microarray analysis of peripheral blood lymphocytes from ALS patients and the SAFE detection of the KEGG ALS pathway.

Authors:  Jean-Luc C Mougeot; Zhen Li; Andrea E Price; Fred A Wright; Benjamin R Brooks
Journal:  BMC Med Genomics       Date:  2011-10-25       Impact factor: 3.063
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.